Glass House Brands (GLAS) Income towards Parent Company (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Income towards Parent Company of -$17.0 million for Q1 2026, down 9.72% quarter-over-quarter from -$15.5 million in Q4 2025.
Glass House Brands (GLAS) Income towards Parent Company (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Income towards Parent Company for 7 consecutive years, with -$17.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Income towards Parent Company changed N/A year-over-year to -$17.0 million; the TTM figure through Mar 2026 stood at -$36.0 million (down 460.39% YoY), while the FY2025 annual figure was -$29.0 million, down 4115.53% from the prior year.
- Income towards Parent Company eased to -$17.0 million in Q1 2026 per GLAS's latest filing, from -$15.5 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $15.2 million in Q3 2022 and bottomed at -$19659.4 billion in Q2 2023.
- Historically, Income towards Parent Company has averaged -$2470.7 billion across 5 years, with a median of -$17.0 million in 2026.
- Annual changes were most pronounced in 2022 — Income towards Parent Company surged 100.0% — and 2023, when it slumped 58.76%.
- Glass House Brands' Income towards Parent Company stood at -$28.4 million in 2022, then plunged by 49.89% to -$42.6 million in 2023, then jumped by 123.47% to $10.0 million in 2024, then tumbled by 255.06% to -$15.5 million in 2025, then dropped by 9.72% to -$17.0 million in 2026.
- Business Quant data shows GLAS's Income towards Parent Company at -$17.0 million in Q1 2026, -$15.5 million in Q4 2025, and -$12.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Glass House Brands | 829.33 Mn | 810.78 Mn | 15.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.01 Mn |
| Dec 31, 2025 | -15.50 Mn |
| Sep 30, 2025 | -12.19 Mn |
| Jun 30, 2025 | 8.67 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Dec 31, 2023 | -42.60 Mn |
| Sep 30, 2023 | 6.28 Mn |
| Jun 30, 2023 | -19,659.40 Bn |
| Mar 31, 2023 | -32.41 Mn |
| Dec 31, 2022 | -28.42 Mn |
| Sep 30, 2022 | 15.17 Mn |
| Jun 30, 2022 | -12,459.44 Bn |
| Mar 31, 2022 | -20.41 Mn |
| Dec 31, 2021 | -22.46 Mn |
| Sep 30, 2021 | -6,955.68 Bn |
| Jun 30, 2021 | -13,606.55 Bn |
| Mar 31, 2021 | -13.15 Mn |
| Dec 31, 2020 | -23,713.35 Bn |
| Sep 30, 2020 | -1.15 Mn |
| Mar 31, 2020 | -5.14 Mn |